Deproto-metallation and computed CH acidity of 2-aryl-1,2,3-triazoles. by Chevallier, Floris et al.
Deproto-metallation and computed CH acidity of
2-aryl-1,2,3-triazoles.
Floris Chevallier, Thomas Blin, Elisabeth Nagaradja, Fre´de´ric Lassagne,
Thierry Roisnel, Yury S Halauko, Vadim E Matulis, Oleg A Ivashkevich,
Florence Mongin
To cite this version:
Floris Chevallier, Thomas Blin, Elisabeth Nagaradja, Fre´de´ric Lassagne, Thierry Roisnel, et al..
Deproto-metallation and computed CH acidity of 2-aryl-1,2,3-triazoles.. Organic and Biomolec-
ular Chemistry, Royal Society of Chemistry, 2012, 10 (25), pp.4878-85. <10.1039/c2ob25554e>.
<hal-01053777>
HAL Id: hal-01053777
https://hal.archives-ouvertes.fr/hal-01053777
Submitted on 1 Aug 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

  
 
 
1 
Deproto-metallation and computed CH acidity of 2-aryl-1,2,3-triazoles† 
Floris Chevallier,*a Thomas Blin,a Elisabeth Nagaradja,a Frédéric Lassagne,a Thierry Roisnel,a 
Yury S. Halauko,*b Vadim E. Matulis,c Oleg A. Ivashkevichc and Florence Mongin*a 
Received (in XXX, XXX) Xth XXXXXXXXX 20XX, Accepted Xth XXXXXXXXX 20XX 
DOI: 10.1039/b000000x 5 
2-Aryl-1,2,3-triazoles were synthesized by cyclization of the corresponding glyoxal arylosazones, 
generated from commercial arylhydrazines. The deproto-metallation of 2-phenyl-1,2,3-triazole was 
attempted using different 2,2,6,6-tetramethylpiperidino-based mixed lithium-metal (Zn, Cd, Cu, Co, Fe) 
combinations, giving results in the case of Zn, Cd, and Cu. The lithium-zinc combination was next 
selected to apply the deprotonation-iodination sequence to all the 2-aryl-1,2,3-triazoles synthesized. The 10 
results were analyzed with the help of the CH acidities of the substrates, determined in THF solution 
using the DFT B3LYP method. 
Introduction 
1,2,3-Triazoles have been shown to exhibit a broad spectrum of 
biological activities, and have found applications as 15 
agrochemicals, dyes, anticorrosive agents and photographic 
materials.1 Even if less described than 1-aryl-1,2,3-triazoles, 
probably in relation with a lack of general synthetic methods,2 2-
aryl-1,2,3-triazoles have found applications, for example as 
optical brighteners.3  20 
 Deprotonative lithiation is an efficient tool to functionalize 
regioselectively heterocycles;4 concerning 1,2,3-triazoles, such a 
possibility has been developed using as substrates 1-substituted 
1,2,3-triazoles, affording after subsequent trapping 5-substituted 
derivatives.5 The reason why no direct lithiation of 2-substituted 25 
1,2,3-triazoles has been documented could be in relation with the 
possible ring opening of the metallated species in this case 
(Scheme 1, S = substituent). 
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Scheme 1 Compared stabilities of the lithio derivatives of 1-substituted 30 
1,2,3-triazoles and 2-substituted 1,2,3-triazole. 
 Combinations of lithium reagents and softer metal compounds 
have recently emerged as efficient tools to deproto-metallate 
sensitive aromatic compounds.6 In search of new bimetal bases 
for tricky deproto-metallations, we developed the use of TMP-35 
based (TMP = 2,2,6,6-tetramethylpiperidino) lithium-zinc,7,8-10 
lithium-cadmium,9,11 lithium-copper(I),12,13 lithium-cobalt14 and 
lithium-iron15 mixtures, prepared by mixing LiTMP with 
MCl2·TMEDA (1/3 equiv, M = Zn, Cd or Cu, TMEDA = 
N,N,N',N'-tetramethylethylenediamine), CuCl (1/2 equiv), CoBr2 40 
(1/3 equiv) or FeBr2 (1/3 equiv).  
 We herein describe our attempts to use these lithium-metal 
combinations for the deproto-metallation of 2-aryl-1,2,3-triazoles. 
The regioselectivity of the reaction being partly determined by 
the acidity of the different hydrogens in the substrate molecule, 45 
the CH acidities of the triazole substrates in THF were calculated 
within the density functional theory (DFT) framework using a 
homodesmic reaction approach described previously,10,16-18 and 
were used to rationalize the outcome of the reactions. 
Results and discussions 50 
Synthetic aspects 
If syntheses of 1-aryl-1,2,3-triazoles have largely been described, 
notably using thermal and Cu(I)- or Ru(II)-catalyzed 
cycloaddition reactions from alkynes and azides, few ways exist 
to synthesize 2-aryl-1,2,3-triazoles.2  55 
 We considered for this purpose the cyclization of glyoxal 
bis(aryl)hydrazones (glyoxal arylosazones), generated from 
commercial arylhydrazines. The Cu(II)-catalyzed method 
developed by Myachina and co-workers in the case of 
phenylhydrazine,19,20 and for which we propose the one electron 60 
mechanism shown in Scheme 2, was followed.  
 In the presence of catalytic copper(II) triflate, the reaction was 
performed either at 150 °C without solvent (Table 1, entries 1, 2 
and 5) or at toluene reflux (Table 1, entries 3 and 4) to furnish the 
expected derivatives 1a-e in yields ranging from 50 to 88%. 65 
 The abilities of the different lithium-metal combinations to 
deproto-metallate 2-phenyl-1,2,3-triazole (1a) were compared 
(Table 2). To this purpose, 1a was first treated with the lithium-
zinc base, in situ prepared from ZnCl2·TMEDA (0.5 equiv) and 
LiTMP (1.5 equiv),21 in THF for 2 h at room temperature before 70 
interception with iodine; under these conditions, two derivatives 
were isolated, the 4-iodo derivative 2a, obtained in 38% yield, 
and the 4,2’-diiodide 3a, isolated in 7% yield (Table 2, entry 1). 
The monoiodide 2a was identified unequivocally by X-ray 
 2 
structure analysis (Fig. 1).‡ Replacing zinc by cadmium led to an 
improved conversion and a more important formation of 3a 
(Table 2, entry 2); such a dideprotonation using the lithium-
cadmium reagent has previously been observed from different 
diactivated substrates.9,11  5 
N
N
N
NHPh
Ph
H
Cu2+
Cu+
N
N
N
NHPh
Ph
H
N
NN
HPh
+
Ph N
H
Ph N
H
H
N
NN
Ph
N
N
N
NHPh
Ph
H
Ph N
H
H
 
Scheme 2 Mechanism proposed to rationalize the Cu(II)-catalyzed 
cyclization of glyoxal phenylosazone. 
Table 1 Synthesis of the 2-aryl-1,2,3-triazoles 1. 
NHNH2.HCl
1- NaOH
2- (CHO)2
3- CuTf2, 
N
NN
1
1
2
3
45
1'
2'
3'
4'
5'
6'
RR
 10 
Entry R Product, Yield (%)a 
1 H 1a, 82 
2 4'-Me 1b, 50 
3 4'-iPr 1c, 61 
4 4'-OMe 1d, 64 
5 3'-Cl 1e, 88 
a
 Overall yield over three steps. 
 
Table 2 Deprotonative metallation of 1a using different lithium-metal 
combinations followed by trapping with electrophiles 
1- MXn (x equiv) +
LiTMP (x(n+1) equiv)
THF, rt, 2 h
2- Electrophile
3- Hydrolysis
N
NN
2a
E
N
NN
1a
N
NN
3a
E
E
4
2'
 15 
Entry MXn (x equiv) Electrophile (E) Product, Yield (%) 
1 ZnCl2·TMEDA (0.5) I2 (I) 2a, 38 3a, 7 
2 CdCl2·TMEDA (0.5) I2 (I) 2a, 46 3a, 14 
3 CuCl (1) PhCOCl (PhCO) 2a', 34 a 
4 CoBr2 (2) I2 (I) a,b a,b 
5 FeBr2 (1) tBuCHO (tBuCH(OH)) a,c a,c 
a
 Not obtained. b Degradation of 1a was noted. c 1a was recovered. 
 
 Using the lithium-copper base, in situ prepared from CuCl (1 
equiv) and LiTMP (2 equiv), under the same reaction conditions 
followed by trapping with benzoyl chloride22 afforded the phenyl 20 
ketone 2a’ in 34% yield (Table 2, entry 3), maybe through the 
thermodynamic metallated species at C4.13 On the other hand, 
using the lithium-cobalt base in situ prepared from CoBr2 (2 
equiv)23 and LiTMP (6 equiv) or the lithium-iron base in situ 
prepared from FeBr2 (1 equiv) and LiTMP (3 equiv) led to 25 
degradation and starting material, respectively (Table 2, entries 
4,5). 
 
Fig. 1 ORTEP diagram (30% probability) of 2a. 
 To avoid concerns about inherent toxicity of cadmium 30 
compounds,24 we decided to pursue the study using the lithium-
zinc base, but prepared from ZnCl2·TMEDA (1 equiv) and 
LiTMP (3 equiv) in order to reach higher conversions (Table 3). 
Starting from 2-phenyl-1,2,3-triazole (1a), the 4,2’-diiodide 3a 
was formed in 56% yield, to the detriment of the 4-iodo 35 
derivative 2a which was obtained in 12% yield; quasi-complete 
conversion and 63% yield for 3a could even be reached by 
doubling the amount of base (Table 3, entry 1).  
Table 3 Deprotonative metallation of 1a-e using mixed Li-Zn base 
followed by trapping with I2. 40 
1- ZnCl2·TMEDA (1 equiv)
+ LiTMP (3 equiv)
THF, rt, 2 h
2- I2
N
NN
2
I
N
NN
1
1
2
3
45
1'
2'
3'
4'
5'
6'
R R
N
NN
3
I
R
N
NN
4
R
I
I
 
Entry Substrate (R) Product, Yield (%) 
1 1a (H) 2a, 12 (2)a 3a (2'-I), 56 (63)a b 
2 1b (4'-Me) 2b, 15 (7)a 3b (2'-I), 32 (58)a 4b, 13 (6)a 
3 1c (4'-iPr) 2c, 36 (12)a 3c (2'-I), 7 (61)a b 
4 1d (4'-OMe) b 3d (2'-I), 35 (56)a,c 
3'd (3'-I), 3 (0)a,c 
4d, 18 (0)a,c 
5 1e (3'-Cl) 2e, 6 (0)a 3e (2'-I), 12 (19)a 
3'e (6'-I), 35 (59)a 
b
 
a
 Deprotonation performed using ZnCl2·TMEDA (2 equiv) + LiTMP (6 
equiv). b Not obtained. c 2-(2,5-diiodo-4-methoxyphenyl)-4-iodo-1,2,3-
triazole (5d) was also isolated in 7% yield. 
 45 
Fig. 2 ORTEP diagrams (30% probability) of 3b and 4b. 
 In the presence of a methyl and, above all, an isopropyl group 
at the 4 position of the phenyl ring (substrates 1b and 1c), the 4-
 3 
iodo derivatives 2b and 2c were formed more significantly. 
However, using ZnCl2·TMEDA (2 equiv) and LiTMP (6 equiv) 
afforded the 4,2’-diiodide 3b and 3c in 58 and 61% yield, 
respectively (Table 3, entries 2,3). In the case of methylated 1b, 
the 4,2’-diiodide 3b as well as the 2'-monoiodo derivative 4b, 5 
which was also obtained (6-13% yield), were identified 
unequivocally by X-ray structure analysis (Fig. 1).‡ No benzylic 
deprotonation was evidenced in these experiments. 
 Anisole being easily ortho-deprotonated under similar reaction 
conditions,8 it was interesting to involve in the deprotonation-10 
iodination sequence 2-(4-methoxyphenyl)-1,2,3-triazole (1d). 
Due to the activating effect of the methoxy group, a complete 
conversion was noted but, as suspected, several products were 
isolated. Using ZnCl2·TMEDA (1 equiv) and LiTMP (3 equiv) 
afforded the 4,2’-diiodide 3d (35% yield), the 2'-monoiodide 4d 15 
(18% yield), and the 4,3'-diiodide 3'd (3% yield); the formation 
of the former could be improved to 56% yield using 
ZnCl2·TMEDA (2 equiv) and LiTMP (6 equiv), but under these 
conditions the 4,2',5'-triiodide 5d also formed and was also 
isolated in 7% yield (Table 3, entry 4). Both the 4,2’-diiodide 3d 20 
and the 4,3'-diiodide 3'd were identified by X-ray diffraction 
from suitable crystals (Fig. 3).‡ 
 
Fig. 3 ORTEP diagrams (30% probability) of 3d and 3'd. 
 With a chloro group at the 3 position of the phenyl group, 25 
things can be more complex due to the loss of symmetry. Upon 
treatment with the lithium-zinc base prepared from 
ZnCl2·TMEDA (1 equiv) and LiTMP (3 equiv), 2-(3-
chlorophenyl)-1,2,3-triazole (1e) was converted to a mixture of 
the 4,6'-diiodide 3'e (35% yield), the 4,2'-diiodide 3e (12% yield) 30 
and the 4-monoiodide 2e (6% yield). Increasing the base amount 
(ZnCl2·TMEDA (2 equiv) and LiTMP (6 equiv)) resulted in the 
exclusive formation of the diiodides 3'e and 3e (59 and 19% 
yield, respectively) (Table 3, entry 5). The structures of all three 
derivatives 2e, 3e, and 3'e were confirmed by X-ray analysis 35 
(Fig. 4).‡  
 
Fig. 4 ORTEP diagrams (30% probability) of 2e (left), 3e (middle) 
and 3'e (right). 
 Benzyne formation was previously evidenced using 40 
Me2Zn(TMP)Li as base;25 in our case, the observed good 
conversion to iodides shows that the elimination of metal chloride 
giving benzyne is not the main reaction. 
Computational aspects 
The data on CH acidity of triazoles are scanty. Fraser reported the 45 
value (26.2) for pKa of 1-propyl-1H-1,2,4-triazole in THF 
solution.26 Substituent CH acidities in DMSO for ethynyltriazoles 
were evaluated and compared with the results computed by 
employing the semi-empirical CNDO 2 method.27 The CH acidity 
of some unsubstituted azoles were also estimated recently within 50 
the DFT framework.28 
 We showed earlier that DFT calculations provide good results 
for gas-phase formation enthalpy29 and basicity30 of triazoles. In 
the present paper, the results of DFT calculations of CH acidity of 
the different 2-aryl-1,2,3-triazoles 1a-e, both in gas phase (see 55 
ESI)† and in THF solution (Scheme 3), are presented. 
 The gas phase acidities acidG and pKa values in THF solution 
of all the triazole substrates were calculated using a theoretical 
approach related to the one previously described. We used it 
successfully to account for mercuration of substituted triazoles,17 60 
trends in CH acidity of N-alkylazoles,18 reactivity of N-aryl 
pyrazoles10 and pyridines.13 
 All the calculations were conducted with the Gaussian 03 
package31 using the DFT B3LYP method. The geometries were 
optimized using the 6-31G(d) basis set (see ESI).† No symmetry 65 
constraints were imposed. In order to perform stationary points 
characterization and to calculate zero-point vibrational energies 
(ZPVE) and thermal corrections to Gibbs free energy, vibrational 
frequencies were calculated at the same level of theory. The 
single point energy calculations were performed using the 6-70 
311+G(d,p) basis set. 
 The gas phase acidities acidG were determined as the Gibbs 
energies of deprotonation of the substrates RH (RH(g)  R(g) 
+ H+(g)). 
 The solvent effects were evaluated using the polarized 75 
continuum model (PCM) with the default parameters for THF.32 
The PCM energies EPCM were calculated at the B3LYP/6-
311+G(d,p) level using geometries optimized for isolated 
structures. The Gibbs energy in solution Gs was calculated for 
each species by the formula: 80 
Gs = G0298 + EPCM  E. 
 To cancel possible inexactnesses, the pKa values were 
calculated by means of the following homodesmic reaction: 
RH(s) + Het(s)  R(s) + HetH(s), 
where HetH is a reference compound, 1-propyl-1H-pyrazole, 85 
stucturally related to the investigated molecules and whose pKa 
value in THF (35.9)26 is supposed to be close to that of 
aryltriazoles. 
 The pKa values were calculated from the Gibbs energies of the 
homodesmic reactions (rGs) using the equation: 90 
r s
a
1
p (R - H) 35.9
ln10
  GK
RT
 
 The CH acidity of side groups such as alkyl and alkoxy, was 
expected to be significantly lower and hence was not considered. 
The results are given below (Scheme 3). 
 For the compounds 1b and 1d, that can exist in form of several 95 
 4 
distinct rotamers, the data on Scheme 3 and in ESI† refer to the 
most stable rotamers. According to our calculations for the 
investigated aryltriazoles, a significant inequality in CH acidity 
between the C3' and C5' sites adjacent to rotatable substituent 
was only noticed in the case of the methoxy derivative 1d.  5 
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Scheme 3 Calculated values of pKa(THF) of the investigated triazoles. 
 Overall the CH acidities of the aryltriazoles correlate with the 
electron-donating or electron-withdrawing effect of the phenyl’s 
substituent. The latter has above all an impact on the reactivity of 10 
the six-membered part of the molecule; the triazole ring, which 
already benefits from high CH acidities, is affected only slightly. 
The chloro substituent exhibits the most prominent acidifying 
effect, providing more variants for synthetic pathways. 
 When the trends in CH acidity of isolated molecules are 15 
compared with the pKas in THF solution, one can see a good 
correlation, described by the equation: 
pKa(THF) = –193.1 + 0.612 acidG 
(N = 20, r2 = 0.948, rmse = 1.07) 
Such a good correlation indicates that the polarities (or dipole 20 
moments) of the different possible anions are close and that there 
is no specific solvation. When compared with gas-phase, 
deprotonation in solution will take place more unlikely at the 3' 
position of the substrate.  
Discussion 25 
The calculations of the CH acidities in THF (Scheme 3) allowed 
us to identify several possible deprotonation sites on the 2-aryl-
1,2,3-triazole substrates. With the exception of the compound 1e, 
for which a 3-chlorophenyl is grafted on the 1,2,3-triazole 2 
position, the most acidic site corresponds to the 4 position of the 30 
azole ring (α to the triazole nitrogen4) whereas the second acidic 
site corresponds to the 2’ position of the aryl group (ortho to the 
triazole substituent4).  
 In general, the main derivatives obtained are at least iodinated 
at their most acidic C4 position. Compared with 2-phenyl-1,2,3-35 
triazole (1a), the derivatives bearing a methyl and an isopropyl 
group at the 4 position of the phenyl ring (substrates 1b and 1c), 
(logically) have lower CH acidities in THF solution. Thus, 
according to calculations, more difficult deproto-metallations are 
expected from the alkylated substrates; the experimental results 40 
using the lithium-zinc base prepared from ZnCl2·TMEDA (1 
equiv) and LiTMP (3 equiv) are in accordance with these 
predictions, with increasing monoiodide/diiodide ratios in the 
order 1a < 1b < 1c. Interestingly, the second experimental 
deprotonation site also corresponds to the second CH acidic site 45 
(Table 3, entries 1-3). It is also important to note that, in the 
absence of other substituent able to coordinate a metal (either of 
the base or of the metallated species), the azole nitrogen can play 
this role and direct the reaction to the 4 and 2’ position.  
 When a methoxy group is introduced at the 4 position of the 50 
phenyl ring (substrate 1d), the neighbouring (ortho and para) 
sites are acidified by its inductive effect whereas the acidity at the 
4 position of the 1,2,3-triazole ring is lowered due to electron-
donation. What is thus expected is a first metallation at C4 and 
further reactions at C2’ or C3’. Experimentally, mixtures were 55 
obtained. If low differences between the different CH acidities 
can be advanced to explain these mixtures, one has also to take 
into account the contribution of the coordinating ability of the 
methoxy group (Table 3, entry 4).  
 The calculations performed on the chloro derivative 1e show 60 
that the halogen exhibits a strong acidifying effect; not only its 
ortho hydrogens, but also those at the meta and para positions are 
significantly acidified.33 In this case, the experimental results 
contrast with an expected reaction at C2'; indeed, if the 4,2'-
diiodide 3e is formed, the main product 3'e results from a second 65 
proton abstraction at C6', which is far from the most acidic site. 
The reason why a major deproto-metallation is not observed at 
C2', in spite of several pKa units in favour of this site, could be 
steric hindrance; a similar result but in the case of 1-(2-
chloropyridin-4-yl)pyrazole has previously been reported.10 70 
Again, the lone pairs of the chloro group or the azole ring can be 
involved in metal complexation with impact on the 
regioselectivity (notably through CH acidity changes).  
Conclusions 
For the first time, 2-aryl-1,2,3-triazoles have been deproto-75 
metallated. These functionalizations were achieved using mixed 
lithium-zinc bases, which are compatible with sensitive substrates 
and do not lead to subsequent ring opening as observed with 
more polar reagents (Scheme 1, right). Once again, mixed alkali 
metal-metal bases proved efficient for the functionalization of 80 
sensitive substrates, as recently observed in pyrazole series.10,34 
The iodo derivatives thus generated could be elaborated, for 
example by Suzuki cross-coupling as shown recently in the 
pyrazole series.10  
 The CH acidities of the substrates in THF solution, which were 85 
calculated using a continuum solvation model, were used to 
rationalize the outcome of the reactions.  
Experimental 
Syntheses: general methods 
Metallation reactions were performed under an argon atmosphere. 90 
THF was distilled over sodium/benzophenone. Column 
chromatography separations were achieved on silica gel (40-63 m). Melting points were measured on a Kofler apparatus. IR 
spectra were taken on a Perkin-Elmer Spectrum 100 
spectrometer. 1H and 13C Nuclear Magnetic Resonance (NMR) 95 
spectra were recorded on a Bruker Avance III spectrometer at 300 
and 75 MHz, respectively. 1H chemical shifts () are given in 
ppm relative to the solvent residual peak, 13C chemical shifts are 
relative to the central peak of the solvent signal,35 and coupling 
constants (J) are given in Hz. Mass spectra (HRMS) 100 
measurements were performed at the CRMPO (Centre Régional 
de Mesures Physiques de l'Ouest) of Rennes using either a Waters 
Q-TOF 2 or a Bruker micrOTOF Q II instrument in positive 
electrospray CI mode. 
 5 
 2-Phenyl-2H-[1,2,3]triazole (1a) was prepared from 
phenylhydrazine hydrochloride using a described procedure.19 
Yield: 82%. Colourless liquid. 1H NMR (CDCl3, 300 MHz) 7.35 
(m, 1H), 7.49 (m, 2H), 7.81 (s, 2H), 8.09 (m, 2H). 13C NMR 
(CDCl3, 75 MHz) 119.1 (2C), 127.7, 129.4 (2C), 135.6 (2C), 5 
140.0. These values are consistent with those reported in the 
literature.20  
 2-(4-Methylphenyl)-2H-[1,2,3]triazole (1b) was prepared 
from 4-methyl-phenylhydrazine hydrochloride using a described 
procedure.19 Yield: 50%. Brown solid (mp = 55 °C). This value is 10 
consistent with that reported in the literature.36 IR (ATR): 3131, 
3044, 2923, 1514, 1411, 1381, 1259, 1151, 961, 951, 817 cm-1. 
1H NMR (CDCl3, 300 MHz) 2.40 (s, 3H), 7.28 (d, 2H, J = 8.2), 
7.79 (s, 2H), 7.95 (d, 2H, J = 8.2). 13C NMR (CDCl3, 75 MHz) 
21.2, 119.0 (2C), 129.9 (2C), 135.3 (2C), 137.6, 137.9. 15 
 2-(4-Isopropylphenyl)-2H-[1,2,3]triazole (1c) was prepared 
from 4-isopropyl-phenylhydrazine hydrochloride using a 
described procedure.19 Yield: 61%. Colourless liquid. IR (ATR): 
2961, 2872, 1516, 1411, 1381, 1260, 1060, 962, 950, 835, 818 
cm-1. 1H NMR (CDCl3, 300 MHz) 1.28 (d, 6H, J = 6.9), 2.97 (m, 20 
1H), 7.34 (d, 2H, J = 8.7), 7.79 (s, 2H), 7.98 (d, 2H, J = 8.7). 13C 
NMR (CDCl3, 75 MHz) 24.1 (2C), 33.9, 119.1 (2C), 127.4 (2C), 
135.4 (2C), 138.0, 148.6. HRMS (ESI): calcd for C11H14N3 
[M+H]+ 188.1188, found 188.1190. 
 2-(4-Methoxyphenyl)-2H-[1,2,3]triazole (1d) was prepared 25 
from 4-methoxy-phenylhydrazine hydrochloride using a 
described procedure.19 Yield: 64%. Colourless liquid. IR (ATR): 
2961, 2839, 1509, 1412, 1246, 1168, 1088, 1028, 952, 829 cm-1. 
1H NMR (CDCl3, 300 MHz) 3.86 (s, 3H), 6.99 (d, 2H, J = 9.2), 
7.77 (s, 2H), 7.98 (d, 2H, J = 9.2). 13C NMR (CDCl3, 75 MHz) 30 
55.7, 114.5 (2C), 120.5 (2C), 133.9, 135.2 (2C), 159.1. HRMS 
(ESI): calcd for C9H10N3O [M+H]+ 176.0824, found 176.0824. 
 2-(3-Chlorophenyl)-2H-[1,2,3]triazole (1e) was prepared 
from 3-chloro-phenylhydrazine hydrochloride using a described 
procedure.19 Yield: 88%. White solid (mp = 45 °C). IR (ATR): 35 
3099, 3079, 1595, 1487, 1409, 1374, 1263, 1105, 961, 952, 822, 
778 cm-1. 1H NMR (CDCl3, 300 MHz) 7.33 (ddd, 1H, J = 1.1, 2.0 
and 8.0 Hz), 7.42 (dd, 1H, J = 8.0 and 8.1 Hz), 7.83 (s, 2H), 7.99 
(ddd, 1H, J = 1.1, 2.1 and 8.1 Hz), 8.13 (dd, 1H, J = 2.0 and 2.1 
Hz). 13C NMR (CDCl3, 75 MHz) 117.1, 119.4, 127.7, 130.5, 40 
135.3, 136.1 (2C), 140.8. HRMS (ESI): calcd for C8H735ClN3 
[M+H]+ 180.03285, found 180.0329. 
 Typical procedure for the deproto-metallation followed by 
trapping with electrophiles. To a stirred, cooled (0 °C) solution 
of 2,2,6,6-tetramethylpiperidine (0.25 mL, 1.5 mmol) in THF (5 45 
mL) was added BuLi (about 1.6 M hexanes solution, 1.5 mmol). 
After 15 min at 0 °C, ZnCl2·TMEDA (0.125 g, 0.5 mmol) was 
added and the mixture was stirred for 15 min at this temperature 
before the introduction of the substrate (1.0 mmol). After 2 h at 
room temperature, a solution of I2 (0.37 g, 1.5 mmol) in THF (5 50 
mL) was added. The mixture was stirred overnight before 
addition of an aqueous saturated solution of Na2S2O3 (10 mL) and 
extraction with Et2O (3 x 20 mL). The combined organic layers 
were washed with brine (20 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure before purification by flash 55 
chromatography on silica gel. 
 4-Iodo-2-phenyl-2H-[1,2,3]triazole (2a). Yellow solid (mp = 
82 °C). IR (ATR): 3123, 3063, 1598, 1497, 1437, 1371, 1354, 
1129, 980, 961, 755 cm-1. 1H NMR (CDCl3, 300 MHz) 7.38 (m, 
1H), 7.50 (m, 2H), 7.86 (s, 1H), 8.04 (m, 2H). 13C NMR (CDCl3, 60 
75 MHz) 91.6, 118.8 (2C), 128.2, 129.5 (2C), 139.5, 142.5. 
HRMS (ESI): calcd for C8H7IN3 [M+H]+ 271.9685, found 
271.9686. 
 Phenyl-(2-phenyl-2H-[1,2,3]-triazol-4-yl)methanone (2a'). 
Brown solid (mp = 158 °C). 1H NMR (CDCl3, 300 MHz) 7.41-65 
7.69 (m, 6H), 8.17 (m, 2H), 8.37 (m, 2H), 8.42 (s, 1H). 13C NMR 
(CDCl3, 75 MHz) 119.6 (2C), 128.6 (2C), 128.7, 129.6 (2C), 
130.5 (2C), 133.6, 136.6, 138.8, 139.5, 147.5, 185.7. These 
values are consistent with those reported in the literature.37  
 4-Iodo-2-(4-methylphenyl)-2H-[1,2,3]triazole (2b). Yellow 70 
solid (mp = 78 °C). IR (ATR): 3124, 3035, 2919, 2857, 1511, 
1440, 1377, 1356, 1128, 980, 960, 815 cm-1. 1H NMR (CDCl3, 
300 MHz) 2.40 (s, 3H), 7.27 (d, 2H, J = 8.6), 7.82 (s, 1H), 7.91 
(d, 2H, J = 8.6). 13C NMR (CDCl3, 75 MHz) 21.2, 91.2, 118.8 
(2C), 130.0 (2C), 140.8, 141.5, 142.3. HRMS (ESI): calcd for 75 
C9H9IN3 [M+H]+ 285.9841, found 285.9841. 
 4-Iodo-2-(4-isopropylphenyl)-2H-[1,2,3]triazole (2c). 
Yellow liquid. IR (ATR): 2959, 2926, 2870, 1513, 1445, 1420, 
1374, 1356, 1128, 1052, 980, 960, 834 cm-1. 1H NMR (CDCl3, 
300 MHz) 1.28 (d, 6H, J = 6.9), 2.96 (m, 1H), 7.32 (d, 2H, J = 80 
8.6), 7.82 (s, 1H), 7.94 (d, 2H, J = 8.6). 13C NMR (CDCl3, 75 
MHz) 24.1 (2C), 33.9, 91.2, 118.8 (2C), 127.4 (2C), 137.6, 142.3, 
149.1. HRMS (ESI): calcd for C11H13IN3 [M+H]+ 314.0154, 
found 314.0150. 
 2-(3-Chlorophenyl)-4-iodo-2H-[1,2,3]triazole (2e). Yellow 85 
solid (mp = 98 °C). IR (ATR): 3132, 3074, 2921, 2851, 1566, 
1455, 1414, 1352, 1261, 1219, 1126, 1023, 980, 962, 840 cm-1. 
1H NMR (CDCl3, 300 MHz) 7.34 (ddd, 1H, J = 1.2, 1.9 and 8.0), 
7.41 (dd, 1H, J = 8.0 and 8.0), 7.85 (s, 1H), 7.94 (ddd, 1H, J = 
1.2, 2.1 and 8.0), 8.09 (dd, 1H, J = 1.9 and 2.1). 13C NMR 90 
(CDCl3, 75 MHz) 92.3, 116.8, 119.1, 128.2, 130.6, 135.4, 140.2, 
143.0. HRMS (ESI): calcd for C8H635ClIN3 [M+H]+ 305.9295, 
found 305.9295. 
 4-Iodo-2-(2-iodophenyl)-2H-[1,2,3]triazole (3a). Yellow 
liquid. IR (ATR): 3052, 2930, 1501, 1479, 1437, 1382, 1264, 95 
1023, 981, 960, 843 cm-1. 1H NMR (CDCl3, 300 MHz) 7.20 (m, 
1H), 7.48 (m, 2H), 7.92 (s, 1H), 8.00 (m, 1H). 13C NMR (CDCl3, 
75 MHz) 91.6, 92.6, 127.8, 129.1, 131.3, 140.7, 141.2, 142.7. 
HRMS (ESI): calcd for C8H6I2N3 [M+H]+ 397.8651, found 
397.8650. 100 
 4-Iodo-2-(2-iodo-4-methylphenyl)-2H-[1,2,3]triazole (3b). 
Yellow solid (mp = 108 °C). IR (ATR): 3132, 2922, 2853, 2431, 
1493, 1431, 1260, 1125, 1027, 979, 962, 839, 821 cm-1. 1H NMR 
(CDCl3, 300 MHz) 2.39 (s, 3H), 7.26 (m, 1H), 7.34 (d, 1H, J = 
8.1), 7.81 (m, 1H), 7.90 (s, 1H). 13C NMR (CDCl3, 75 MHz) 105 
20.9, 91.3, 92.5, 127.3, 129.7, 140.5, 140.8, 141.9, 142.5. HRMS 
(ESI): calcd for C9H8I2N3 [M+H]+ 411.8808, found 411.8811. 
 4-Iodo-2-(2-iodo-4-isopropylphenyl)-2H-[1,2,3]triazole (3c). 
Yellow liquid. IR (ATR): 3003, 2960, 2932, 1709, 1421, 1359, 
1221, 1092, 982, 962, 902 cm-1. 1H NMR (CDCl3, 300 MHz) 1.27 110 
(d, 6H, J = 6.9), 2.94 (m, 1H), 7.31 (dd, 1H, J = 1.8 and 8.1), 7.37 
 6 
(d, 1H, J = 8.1), 7.82 (d, 1H, J = 1.8), 7.90 (s, 1H). 13C NMR 
(CDCl3, 75 MHz) 23.9 (2C), 33.8, 91.3, 92.8, 127.2, 127.5, 
138.5, 140.6, 142.5, 152.8. HRMS (ESI): calcd for C11H12I2N3 
[M+H]+ 439.9121, found 439.9105. 
 4-Iodo-2-(2-iodo-4-methoxyphenyl)-2H-[1,2,3]triazole (3d). 5 
Yellow solid (mp = 58 °C). IR (ATR): 2968, 2935, 2839, 1593, 
1569, 1495, 1439, 1295, 1264, 1239, 1227, 1029, 1018, 980, 960, 
841 cm-1. 1H NMR (CDCl3, 300 MHz) 3.85 (s, 3H), 6.97 (dd, 1H, 
J = 2.7 and 8.8), 7.35 (d, 1H, J = 8.8), 7.46 (d, 1H, J = 2.7), 7.89 
(s, 1H). 13C NMR (CDCl3, 75 MHz) 56.0, 91.2, 93.7, 114.6, 10 
125.1, 128.3, 136.3, 142.4, 160.7. HRMS (ESI): calcd for 
C9H7I2NaN3O [M+Na]+ 449.8576, found 449.8570. 
 4-Iodo-2-(3-iodo-4-methoxyphenyl)-2H-[1,2,3]triazole (3'd). 
Yellow solid (mp = 140 °C). IR (ATR): 2939, 2841, 1493, 1440, 
1269, 1245, 1043, 1017, 981, 965, 809 cm-1. 1H NMR (CDCl3, 15 
300 MHz) 3.93 (s, 3H), 6.88 (d, 1H, J = 8.9), 7.81 (s, 1H), 7.98 
(dd, 1H, J = 2.6 and 8.9), 8.47 (d, 1H, J = 2.6). 13C NMR (CDCl3, 
75 MHz) 56.9, 85.9, 91.4, 110.6, 120.0, 129.9, 133.9, 142.4, 
158.1. HRMS (ESI): calcd for C9H8I2N3O [M+H]+ 427.8757, 
found 427.8748. 20 
 2-(3-Chloro-2-iodophenyl)-4-iodo-2H-[1,2,3]triazole (3e). 
Yellow solid (mp = 84 °C). IR (ATR): 2924, 2849, 1594, 1483, 
1455, 1432, 1371, 1353, 1128, 982, 963, 779 cm-1. 1H NMR 
(CDCl3, 300 MHz) 7.31 (dd, 1H, J = 1.5 and 7.9), 7.42 (dd, 1H, J 
= 7.9 and 8.0), 7.61 (dd, 1H, J = 1.5 and 8.0), 7.92 (s, 1H). 13C 25 
NMR (CDCl3, 75 MHz) 91.8, 99.6, 126.0, 129.7, 130.7, 141.0, 
142.8, 145.0. HRMS (ESI): calcd for C8H535ClI2N3 [M+H]+ 
431.8261, found 431.8262. 
 2-(5-Chloro-2-iodophenyl)-4-iodo-2H-[1,2,3]triazole (3'e). 
Yellow solid (mp = 102 °C). IR (ATR): 3127, 3086, 2926, 1577, 30 
1561, 1472, 1442, 1414, 1352, 1099, 1019, 981, 961, 874, 815 
cm-1. 1H NMR (CDCl3, 300 MHz) 7.19 (dd, 1H, J = 2.4 and 8.5), 
7.51 (d, 1H, J = 2.4), 7.91 (d, 1H, J = 8.5), 7.92 (s, 1H). 13C NMR 
(CDCl3, 75 MHz) 89.2, 82.2, 127.8, 131.3, 135.1, 141.5, 143.0, 
143.3. HRMS (ESI): calcd for C8H535ClI2N3 [M+H]+ 431.8261, 35 
found 431.8270. 
 2-(2-Iodo-4-methylphenyl)-2H-[1,2,3]triazole (4b). Brown 
solid (mp = 124 °C). IR (ATR): 3139, 2956, 2922, 1514, 1498, 
1411, 1251, 1150, 1024, 962, 951, 819 cm-1. 1H NMR (CDCl3, 
300 MHz) 2.40 (s, 3H), 7.27 (m, 1H), 7.35 (d, 1H, J = 8.1), 7.82 40 
(m, 1H), 7.87 (s, 2H). 13C NMR (CDCl3, 75 MHz) 20.8, 92.8, 
127.4, 129.7, 135.5 (2C), 140.8, 141.0, 141.5. HRMS (ESI): 
calcd for C9H9IN3 [M+H]+ 285.9841, found 285.9838. 
 2-(2-Iodo-4-methoxyphenyl)-2H-[1,2,3]triazole (4d). Orange 
solid (mp = 92 °C) which rapidly decomposes by loss of iodine. 45 
1H NMR (CDCl3, 300 MHz) 3.86 (s, 3H), 6.84 (dd, 1H, J = 2.7 
and 8.8), 7.36 (d, 1H, J = 8.8), 7.48 (d, 1H, J = 2.7), 7.86 (s, 2H). 
 2-(2,5-Diiodo-4-methoxyphenyl)-4-iodo-2H-[1,2,3]triazole 
(5d). Yellow liquid. IR (ATR): 3120, 2968, 2936, 2841, 1485, 
1437, 1333, 1241, 1043, 1019, 981, 961, 838, 820 cm-1. 1H NMR 50 
(CDCl3, 300 MHz) 3.95 (s, 3H), 7.28 (s, 1H), 7.82 (s, 1H), 7.89 
(s, 1H). 13C NMR (CDCl3, 75 MHz) 57.2, 85.3, 91.6, 92.9, 121.2, 
137.1, 137.5, 142.7, 159.5. HRMS (ESI): calcd for C9H6I3NaN3O 
[M+Na]+ 575.7543, found 575.7545. 
Crystallography 55 
Single crystals suitable for X-ray diffraction were grown after 
slow evaporation of solutions of 2a, 2e, 3b, 3d, 3'd, 3e, 3'e and 
4b in dichloromethane at room temperature. 
 The samples were studied with graphite monochromatized Mo-
K radiation ( = 0.71073 Å). X-ray diffraction data were 60 
collected at T = 150(2) K using APEXII Bruker-AXS 
diffractometer. The structure was solved by direct methods using 
the SIR97 program,38 and then refined with full-matrix least-
square methods based on F2 (SHELX-97)39 with the aid of the 
WINGX program.40 All non-hydrogen atoms were refined with 65 
anisotropic thermal parameters. H atoms were finally included in 
their calculated positions. Except N-linked hydrogen that was 
introduced in the structural model through Fourier difference 
maps analysis, H atoms were finally included in their calculated 
positions. Molecular diagrams were generated by ORTEP-3 70 
(version 2.02).41  
 Crystal data for 2a. C8H6IN3, Mr = 271.06, orthorhombic, 
Pc21n, a = 4.3176(3), b = 13.3505(10), c = 15.2661(12) Å, V = 
879.97(11) Å3, Z = 4, c = 2.046 g cm-3,  = 3.584 mm-1. A final 
refinement on F2 with 1992 unique intensities and 109 parameters 75 
converged at wR(F2) = 0.0398 (R(F) = 0.0183) for 1792 observed 
reflections with I > 2(I). 
 Crystal data for 2e. C8H5ClIN3, Mr = 305.50, orthorhombic, 
Pc21n, a = 4.2056(5), b = 13.2551(18), c = 17.169(2) Å, V = 
957.1(2) Å3, Z = 4, c = 2.12 g cm-3,  = 3.578 mm-1. A final 80 
refinement on F2 with 2164 unique intensities and 118 parameters 
converged at wR(F2) = 0.0418 (R(F) = 0.0183) for 2059 observed 
reflections with I > 2(I). 
 Crystal data for 3b. C9H7I2N3, Mr = 410.98, monoclinic, 
P21/c, a = 10.3473(15), b = 7.1028(8), c = 15.555(2) Å,  = 85 
104.138(6) °, V = 1108.6(2) Å3, Z = 4, c = 2.462 g cm-3,  = 
5.638 mm-1. A final refinement on F2 with 2544 unique 
intensities and 128 parameters converged at wR(F2) = 0.0588 
(R(F) = 0.0249) for 2320 observed reflections with I > 2(I). 
 Crystal data for 3d. 2(C9H7I2N3O), Mr = 853.95, triclinic, P-90 
1, a = 7.7817(6), b = 10.5301(8), c = 14.2726(11) Å,  = 
79.833(4),  = 89.092(4),  = 80.124(4) °, V = 1133.98(15) Å3, Z 
= 2, c = 2.501 g cm-3,  = 5.524 mm-1. A final refinement on F2 
with 5165 unique intensities and 273 parameters converged at 
wR(F2) = 0.0895 (R(F) = 0.0374) for 4179 observed reflections 95 
with I > 2(I). 
 Crystal data for 3'd. C9H7I2N3O, Mr = 426.98, orthorhombic, 
Pc21n, a = 4.1304(2), b = 12.9948(5), c = 21.5358(9) Å, V = 
1155.91(9) Å3, Z = 4, c = 2.454 g cm-3,  = 5.419 mm-1. A final 
refinement on F2 with 2314 unique intensities and 137 parameters 100 
converged at wR(F2) = 0.0498 (R(F) = 0.0228) for 2273 observed 
reflections with I > 2(I). 
 Crystal data for 3e. C8H4ClI2N3, Mr = 431.39, orthorhombic, 
P21cn, a = 7.8011(19), b = 9.106(2), c = 15.558(4) Å, V = 
1105.2(5) Å3, Z = 4, c = 2.593 g cm-3,  = 5.896 mm-1. A final 105 
refinement on F2 with 2515 unique intensities and 127 parameters 
converged at wR(F2) = 0.0386 (R(F) = 0.0178) for 2480 observed 
reflections with I > 2(I). 
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 Crystal data for 3'e. C8H4ClI2N3, Mr = 431.39, monoclinic, 
P21/c, a = 10.8653(4), b = 7.7070(2), c = 13.2464(5) Å,  = 
93.5294(18) °, V = 1107.13(7) Å3, Z = 4, c = 2.588 g cm-3,  = 
5.886 mm-1. A final refinement on F2 with 2508 unique 
intensities and 127 parameters converged at wR(F2) = 0.056 5 
(R(F) = 0.0224) for 2368 observed reflections with I > 2(I). 
 Crystal data for 4b. C9H8IN3, Mr = 285.08, monoclinic, 
P21/n, a = 7.993(2), b = 14.366(4), c = 8.736(2) Å,  = 
94.686(13) °, V = 999.8(4) Å3, Z = 4, c = 1.894 g cm-3,  = 3.160 
mm-1. A final refinement on F2 with 2254 unique intensities and 10 
119 parameters converged at wR(F2) = 0.0783 (R(F) = 0.0337) 
for 2096 observed reflections with I > 2(I). 
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2-Aryl-1,2,3-triazoles have been synthesized and deproto-metallated
using a 2,2,6,6-tetramethylpiperidino-based lithium-zinc combination.
The outcome of the reactions has been discussed in the light of DFT-
calculated CH acidities (THF solution).
N
NN 1) ZnCl2·TMEDA (2 equiv)
+ LiTMP (6 equiv)
THF, rt, 2 h
2) I2
N
NN
4
2'
4'
5'
R
I
I
R
R = H, 4'-Me, 4'-iPr, 4'-OMe, 5'-Cl: 56-63% yield
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